PMPhilip Morris International Inc.(PM)Stock Analysis

AI analysis on 2,800+ stocks →
Consumer StaplesNYSE
Institutional-grade research for retail investors
SEC EDGAR: CIK 1413329PM stock profile & AI dashboard →

13F Pro Quality Score

80.5/100

Rank #41 of 2,879 stocksTOP 5%

View Consumer Staples peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

58.9/100

Profitability

90.8/100

Balance Sheet

94.8/100

Earnings Quality

70.5/100

Free Cash Flow

71.2/100

Institutional Flow

58.7/100

Revenue Scale

96.5/100

Dilution Risk

94.9/100

PM Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Philip Morris International Inc. (PM), a Consumer Staples sector company. 13F Pro's AI-powered ranking engine scores PM at 80.5/100 on a 32-signal composite quality model, placing it at rank #41 of 2,879 stocks — the top 5% of the AI-ranked universe. PM scores in the top quartile across revenue scale (96.5), balance sheet strength (94.8), profitability (90.8). Based on the latest XBRL financial filings (Q1 2026), Philip Morris International Inc. reports quarterly revenue of $10.1B, net income of $2.4B, an operating margin of 38.4%. Top institutional holders of PM by reported 13-F value include Capital World Investors, BlackRock,, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. PM trades on the NYSE exchange and files with the SEC under CIK 1413329. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PM daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Philip Morris International Inc. directly from SEC EDGAR. Philip Morris International Inc.'s 13F Pro composite quality score has ranged between 51 and 85 since 2021, currently 80.5 — an improving long-term trajectory across 56 quarterly and live scoring snapshots.

Fun facts about Philip Morris International Inc.

Quirks, history, and lore behind PM — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    A consumer staples company · NYSE-listed · mega-cap · headquartered in Connecticut.
  • 2
    The Numbers
    Pulls in roughly $35 billion in annual revenue with operating margins that make most industries weep — over 40% — because its customers are, shall we say, highly motivated repeat buyers.
  • 3
    The History
    Spun off from its American parent in 2008 specifically to operate outside the United States, instantly becoming one of the largest consumer goods companies on the planet.
  • 4
    The Secret
    It sells no products legally in the U.S., yet American investors love it for its fat dividend — it has returned tens of billions to shareholders since its spinoff.
  • 5
    The Lore
    It's betting its future on a smoke-free world — its flagship heated tobacco device is now sold in over 70 countries and is quietly cannibalizing its own legacy business.
  • 6
    The Giveaway
    The maker of the world's best-selling cigarette brand — Marlboro internationally — is racing to replace it with IQOS before the world quits on them first.
▶ Think you know your stocks? Play the Daily Ticker

What's Driving PM's Business? Latest 10-Q Breakdown

AI-extracted from Philip Morris International Inc.'s 10-Q filed 2026-04-24 — Q1 2026 (quarter ended March 31, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

Net revenues increased 9.1% to $10.1B, driven by favorable pricing and smoke-free product growth, though diluted EPS declined 9.3% to $1.56 due to unfavorable fair value adjustments on equity investments.

Biggest Revenue Drivers

Total revenue: $10.1B+9.1% YoY

International Combustibles$5.7B+6.8% YoY

Favorable pricing partly offset by unfavorable volume/mix and lower cigarette volumes in Indonesia, Russia, Germany, and Mexico.

International Smoke-Free$3.8B+24.7% YoY

Higher HTU and e-vapor volumes and favorable HTU pricing, notably from Italy, Global Travel Retail, Taiwan, and Russia.

U.S.$622M-30.8% YoY

Lower ZYN volumes due to distributor and trade inventory movements and unfavorable price comparison from low promotional activity in prior year.

Largest Expense Items

Cost of sales$3.2B+6.9% YoY

Higher manufacturing costs in U.S. segment; favorable pricing variance and cost benefits in International Smoke-Free partly offset unfavorable volume/mix.

Marketing, administration and research costs$2.9B+17.7% YoY

Includes $24M restructuring charges related to U.S. footprint optimization and Further Integration Program; higher operating costs.

Interest expense, net$237M-1.7% YoY

Minimal change from prior year period.

Watch Items from the Filing

  • U.S. oral smoke-free products volume declined 21.3% to 2.8B units; ZYN shipments down 23.5% due to distributor inventory movements and challenging promotional comparison, though Nielsen offtake grew 10%.
  • Germany heated tobacco products supplemental tax surcharge: PMI paid EUR 721M ($751M) in January 2025 pending appeal outcome; unfavorable ruling would negatively impact future cash flow; favorable outcome would benefit future results.
  • Fair value loss on equity securities (India, Sri Lanka) of $338M after-tax ($0.22 per diluted EPS) in Q1 2026 vs. $143M after-tax gain ($0.09 per share) in Q1 2025; significant volatility in these investments.
  • Russia represents approximately 9% of total shipment volume and 6% of net revenues; carries material risks from ongoing geopolitical tensions, currency devaluation, and potential asset impairment if divestment becomes necessary.
  • Litigation related to ZYN nicotine pouches: Multiple cases filed since March 2024; Kelly class action moved to discovery with trial scheduled December 2026; Baltimore case pending remand decision; material outcomes remain uncertain.

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Revenue

Q1 2026

$10.1B

Net Income

Q1 2026

$2.4B

Free Cash Flow

Q1 2026

$-752.0M

Operating Margin

Q1 2026

38.4%

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+7.7% YoY
$37.88BFY 2024
FY21 $31.41BFY22 $31.76BFY23 $35.17BFY24 $37.88B

Net Income

-9.7% YoY
$7.06BFY 2024
FY21 $9.11BFY22 $9.05BFY23 $7.81BFY24 $7.06B

Operating Income

+16.0% YoY
$13.40BFY 2024
FY21 $12.97BFY22 $12.25BFY23 $11.56BFY24 $13.40B

EPS (Diluted)

-10.0% YoY
$4.52FY 2024
FY21 $5.83FY22 $5.81FY23 $5.02FY24 $4.52

Total Assets

-5.4% YoY
$61.78BFY 2024
FY21 $41.29BFY22 $61.68BFY23 $65.30BFY24 $61.78B

Total Debt

-4.6% YoY
$45.70BFY 2024
FY21 $27.81BFY22 $43.12BFY23 $47.91BFY24 $45.70B

Op. Cash Flow

+32.7% YoY
$12.22BFY 2024
FY21 $11.97BFY22 $10.80BFY23 $9.20BFY24 $12.22B

AI Insight: PM Financial Trends

Philip Morris delivered strong revenue growth with Q1 2026 sales up 9% year-over-year, but persistent negative equity signals heavy debt burden concerns.

Revenue grew from $9,301M in Q1 2025 to $10,146M in Q1 2026, representing 9.1% year-over-year growth.

Operating income improved from $3,544M in Q1 2025 to $3,893M in Q1 2026, up 9.8% year-over-year.

Total debt increased from $49,579M in Q1 2025 to $51,948M in Q1 2026, rising $2.4B.

Equity remains deeply negative at -$9,279M in Q1 2026, though improved from -$10,901M in Q1 2025.

Operating cash flow turned negative in both Q1 2025 and Q1 2026, showing seasonal weakness.

Net income volatility with Q4 2024 loss of $579M followed by recovery in subsequent quarters.

AI Insight: PM Ratio Trends

Philip Morris shows volatile but resilient profitability with operating margins consistently above 32% despite Q4 seasonal weakness.

Operating margin peaked at 39.3% in Q3 2025, demonstrating strong pricing power and cost control.

Net profit margin recovered to 24.0% in Q1 2026 after Q4 2025's drop to 20.7%.

ROIC reached 43.5% in Q3 2025, the highest level across all quarters shown.

Q4 seasonal margin compression pattern persists, with operating margin falling to 32.6% in Q4 2025.

Q4 2024 showed negative net margin of -6.0%, indicating potential for significant one-off impacts.

Get alerted when PM's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Philip Morris International Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of PM

Put PM on your watchlist

Track score changes the day Philip Morris International Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is PM a good stock to buy?

13F Pro's AI-powered analysis of Philip Morris International Inc. (PM) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Consumer Staples sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for PM are available on the PM stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own PM?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling PM. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Philip Morris International Inc.'s investment landscape.